Ocular Therapeutix, Inc files SEC 8-K: Departure or Election of Directors or Certain Officers

Ocular Therapeutix, Inc filed a Form 8-K on Monday, 9 November 2026 reporting Departure or Election of Directors or Certain Officers.

Published on by

Ocular Therapeutix, Inc filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) at 12:28 UTC on Monday, 9 November 2026. The filing reports Item 5.02, Departure or Election of Directors or Certain Officers.

A Form 8-K is the report U.S. public companies file to tell investors about significant events between their regular quarterly and annual reports. Each item in the form covers one type of event.

Source: U.S. Securities and Exchange Commission (EDGAR) filing

More on this Story & Related In-Depth Reports

Markets & Finance

Air Industries Group (the “Company”) issued a press release reporting its financial results for the three and nine

AIR Industries Group filed a Form 8-K at 12:43 UTC on Monday, 9 November 2026....

Markets & Finance

RadNet, Inc.: Inc. issued a press release regarding its financial results for the Third quarter ended September 30

RadNet, Inc. filed a Form 8-K at 12:50 UTC on Monday, 9 November 2026. Inc. issued a press release regarding its financi...

Markets & Finance

AN2 Therapeutics, Inc. files SEC 8-K: Results of Operations and Financial Condition

AN2 Therapeutics, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) at 12:31 UTC on Monday, 9...

Markets & Finance

Goodyear Tire & Rubber Co /Oh/ files SEC 8-K: Departure or Election of Directors or Certain Officers

Goodyear Tire & Rubber Co /Oh/ filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) at 12:32 UTC on M...